Read More Pharma Industry News Kinnate Biopharma agrees to merger with XOMA, boosting shareholder value and advancing cancer research Kinnate Biopharma Inc. (Nasdaq: KNTE), a leading clinical-stage precision oncology company, has announced a definitive merger agreement with… byPallavi MadhirajuFebruary 18, 2024